Merck Tbk PT operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck Tbk PT with three other
pharmaceutical manufacturers in Asia:
Qianjiang Yongan Pharmaceutical Co Ltd
sales of 549.40 million Chinese Renmimbi [US$83.37 million]
of which 84%
was Medical Manufacturing),
Ttk Healthcare Limited
(5.19 billion Indian Rupees [US$80.22 million]
of which 53%
was Pharmaceuticals), and
Taiko Pharmaceutical Company., Limited
based in Japan
(8.33 billion Japanese Yen [US$74.20 million]
of which 73%
was Medicine Goods).
Merck Tbk PT reported sales of 1.03 trillion Indonesian Rupiahs (US$76.78 million)
December of 2016.
increase of 5.2%
versus 2015, when the company's sales were 983.45 billion Indonesian Rupiahs.
Sales of Consumer Healthcare saw an increase
that was more than double the company's growth rate: sales were up
11.3% in 2016, from
455.11 billion Indonesian Rupiahs to 506.50 billion Indonesian Rupiahs.
Not all segments of Merck Tbk PT experienced an increase in sales in 2016:
sales of Others fell 0.4% to 89.90 billion Indonesian Rupiahs.